Cargando…

Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis

BACKGROUND: Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wanwan, Zhang, Lingmin, Sheng, Lingling, Zhang, Zhencheng, Yang, Zaixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809835/
https://www.ncbi.nlm.nih.gov/pubmed/33446257
http://dx.doi.org/10.1186/s13098-021-00624-9
_version_ 1783637196045025280
author Luo, Wanwan
Zhang, Lingmin
Sheng, Lingling
Zhang, Zhencheng
Yang, Zaixing
author_facet Luo, Wanwan
Zhang, Lingmin
Sheng, Lingling
Zhang, Zhencheng
Yang, Zaixing
author_sort Luo, Wanwan
collection PubMed
description BACKGROUND: Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker of inflammation and some studies have indicated that DM was related with inflammation. The objective of our study is to perform a systematic review and meta-analysis to confirm the relationship between YKL-40 and DM as well as DN. METHODS: Pubmed, Embase, CNKI and Chinese wanfang databases were searched for eligible studies by two independent authors. Studies were included in this meta-analysis if they fulfilled the following inclusion criteria: (1) a study involving the role of YKL-40 in DM (or DN) designed as a case–control study or cohort study; (2) the data of serum YKL-40 levels were available; (3) studies were published in English or Chinese. Finally, twenty-five studies were included in this meta-analysis. RESULTS: Compared with healthy controls, DM patients had significantly higher levels of YKL-40 (DM: SMD = 1.62, 95% CI 1.08 to 2.25, P = 0.000; GDM: SMD = 2.85, 95% CI 1.01 to 4.70, P = 0.002). Additionally, DM patients with different degree of albuminuria had significantly higher levels of YKL-40 compared with healthy controls (normoalbuminuria: SMD = 1.58, 95% CI 0.59 to 2.56, P = 0.002; microalbuminuria: SMD = 2.57, 95% CI 0.92 to 4.22, P = 0.002; macroalbuminuria: SMD = 2.69, 95% CI 1.40 to 3.98, P = 0.000) and serum YKL-40 levels increased with increasing severity of albuminuria among DM patients (microalbuminuria vs normoalbuminuria: SMD = 1.49, 95% CI 0.28 to 2.71, P = 0.016; macroalbuminuria vs microalbuminuria: SMD = 0.93, 95% CI 0.34 to 1.52, P = 0.002). CONCLUSIONS: Our current meta-analysis demonstrates that serum level of YKL-40 is increased in DM and positively associated with the severe degree of albuminuria. Therefore, we suggest that YKL-40 could be considered to be detected, along with other inflammatory markers, if DM, especially DN, is suspected.
format Online
Article
Text
id pubmed-7809835
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78098352021-01-18 Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis Luo, Wanwan Zhang, Lingmin Sheng, Lingling Zhang, Zhencheng Yang, Zaixing Diabetol Metab Syndr Research BACKGROUND: Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker of inflammation and some studies have indicated that DM was related with inflammation. The objective of our study is to perform a systematic review and meta-analysis to confirm the relationship between YKL-40 and DM as well as DN. METHODS: Pubmed, Embase, CNKI and Chinese wanfang databases were searched for eligible studies by two independent authors. Studies were included in this meta-analysis if they fulfilled the following inclusion criteria: (1) a study involving the role of YKL-40 in DM (or DN) designed as a case–control study or cohort study; (2) the data of serum YKL-40 levels were available; (3) studies were published in English or Chinese. Finally, twenty-five studies were included in this meta-analysis. RESULTS: Compared with healthy controls, DM patients had significantly higher levels of YKL-40 (DM: SMD = 1.62, 95% CI 1.08 to 2.25, P = 0.000; GDM: SMD = 2.85, 95% CI 1.01 to 4.70, P = 0.002). Additionally, DM patients with different degree of albuminuria had significantly higher levels of YKL-40 compared with healthy controls (normoalbuminuria: SMD = 1.58, 95% CI 0.59 to 2.56, P = 0.002; microalbuminuria: SMD = 2.57, 95% CI 0.92 to 4.22, P = 0.002; macroalbuminuria: SMD = 2.69, 95% CI 1.40 to 3.98, P = 0.000) and serum YKL-40 levels increased with increasing severity of albuminuria among DM patients (microalbuminuria vs normoalbuminuria: SMD = 1.49, 95% CI 0.28 to 2.71, P = 0.016; macroalbuminuria vs microalbuminuria: SMD = 0.93, 95% CI 0.34 to 1.52, P = 0.002). CONCLUSIONS: Our current meta-analysis demonstrates that serum level of YKL-40 is increased in DM and positively associated with the severe degree of albuminuria. Therefore, we suggest that YKL-40 could be considered to be detected, along with other inflammatory markers, if DM, especially DN, is suspected. BioMed Central 2021-01-15 /pmc/articles/PMC7809835/ /pubmed/33446257 http://dx.doi.org/10.1186/s13098-021-00624-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Luo, Wanwan
Zhang, Lingmin
Sheng, Lingling
Zhang, Zhencheng
Yang, Zaixing
Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
title Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
title_full Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
title_fullStr Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
title_full_unstemmed Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
title_short Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis
title_sort increased levels of ykl-40 in patients with diabetes mellitus: a systematic review and meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809835/
https://www.ncbi.nlm.nih.gov/pubmed/33446257
http://dx.doi.org/10.1186/s13098-021-00624-9
work_keys_str_mv AT luowanwan increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis
AT zhanglingmin increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis
AT shenglingling increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis
AT zhangzhencheng increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis
AT yangzaixing increasedlevelsofykl40inpatientswithdiabetesmellitusasystematicreviewandmetaanalysis